$250 | Single User Price
$500 | Site License Price
$750 | Enterprise License Price

NeoGenomics Inc (NEO) - Medical Equipment - Deals and Alliances Profile [Report Updated: 17-07-2017]

Published by Global Data: 17 Jul 2017 | 106227 | In Stock

Introduction

Summary

NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, and molecular genetics including sanger sequencing and fragment analysis. It also offers APvX, LIS/EMR integration and tech-only services. NeoGenomics’s biopharma services support drug development programs ranging from early biomarker discovery to clinical trials. The company caters to oncologists, pathologists, pharmaceutical companies, academic centers, and others. It operates through its subsidiaries. NeoGenomics is headquartered in Fort Myers, Florida, the US.

NeoGenomics Inc (NEO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for NeoGenomics Inc (NEO) - Medical Equipment - Deals and Alliances Profile [Report Updated: 17-07-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    NeoGenomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

    NeoGenomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

    NeoGenomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

    NeoGenomics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

    NeoGenomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

    NeoGenomics Inc, Medical Equipment, Deal Details 11

    Partnerships 11

    Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 11

    Health Discovery Enters Into Licensing Agreement With NeoGenomics 11

    NeoGenomics and Definiens Enter into Agreement 13

    Arno Therapeutics Enters Into Co-Development Agreement With Clarient Diagnostic Services 13

    Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit 14

    Biocept Enters Into Co-Marketing Agreement With Clarient 15

    Signal Genetics Enters Into Co-Marketing Agreement With NeoGenomics 16

    CombiMatrix Enters Into An Agreement With Clarient 17

    Equity Offering 18

    NeoGenomics Raises USD37 Million in Public Offering of Shares 18

    NeoGenomics Completes Public Offering Of Shares For US Million 19

    NeoGenomics Completes Private Placement Of Common Stock For US Million 20

    Acquisition 21

    NeoGenomics Acquires Clarient from GE Healthcare 21

    GE Healthcare Completes Acquisition Of Clarient 23

    NeoGenomics Inc - Key Competitors 26

    Key Employees 27

    Locations And Subsidiaries 28

    Head Office 28

    Other Locations & Subsidiaries 28

    Recent Developments 29

    Financial Announcements 29

    Apr 26, 2017: NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017 29

    Feb 22, 2017: NeoGenomics Reports 122% Revenue Growth to .5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016 31

    Oct 26, 2016: NeoGenomics Reports 142% Revenue Growth to .8 Million and a Record .6 Million in Cash Flow from Operations in the Third Quarter of 2016 33

    Jul 26, 2016: NeoGenomics Reports 159% Revenue Growth to .1 Million and Strong Gains in Profitability in the Second Quarter of 2016 35

    Apr 27, 2016: NeoGenomics Reports 159% Revenue growth to .7 Million and 442% Adjusted EBITDA increase to .2 Million, Driven by Clarient acquisition and Strong Volume Gains 37

    Mar 01, 2016: NeoGenomics Reports Record Revenue of .2 Million and Record Adjusted EBITDA of .9 Million in Fourth Quarter, Driven by Strong Volume Gains 39

    Corporate Communications 41

    Apr 20, 2017: NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development 41

    Product News 42

    Jun 02, 2017: NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests 42

    Appendix 43

    Methodology 43

    About GlobalData 43

    Contact Us 43

    Disclaimer 43

List Of Tables
in NeoGenomics Inc (NEO) - Medical Equipment - Deals and Alliances Profile [Report Updated: 17-07-2017]

List of Tables

NeoGenomics Inc, Medical Equipment, Key Facts, 2016 1

NeoGenomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

NeoGenomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

NeoGenomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

NeoGenomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

NeoGenomics Inc, Deals By Market, 2011 to YTD 2017 9

NeoGenomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker 11

Health Discovery Enters Into Licensing Agreement With NeoGenomics 11

NeoGenomics and Definiens Enter into Agreement 13

Arno Therapeutics Enters Into Co-Development Agreement With Clarient Diagnostic Services 13

Qiagen Enters Into Agreement With Clarient To Offer therascreen KRAS RGQ PCR Kit 14

Biocept Enters Into Co-Marketing Agreement With Clarient 15

Signal Genetics Enters Into Co-Marketing Agreement With NeoGenomics 16

CombiMatrix Enters Into An Agreement With Clarient 17

NeoGenomics Raises USD37 Million in Public Offering of Shares 18

NeoGenomics Completes Public Offering Of Shares For US Million 19

NeoGenomics Completes Private Placement Of Common Stock For US Million 20

NeoGenomics Acquires Clarient from GE Healthcare 21

GE Healthcare Completes Acquisition Of Clarient 23

NeoGenomics Inc, Key Competitors 26

NeoGenomics Inc, Key Employees 27

NeoGenomics Inc, Other Locations 28

NeoGenomics Inc, Subsidiaries 28

Additional Details

Publisher

Global Data

Publisher Information

Reference

106227 | GDME7054D

Number of Pages

43

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
NeoGenomics Inc (NEO) - Financial and Strategic SWOT Analysis Review
SummaryNeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers...
13 Nov 2017 by Global Data USD $300 More Info
NeoGenomics Inc (NEO) - Financial and Strategic SWOT Analysis Review
SummaryNeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers...
07 Aug 2017 by Global Data USD $300 More Info
NeoGenomics Inc (NEO) - Financial and Strategic SWOT Analysis Review
SummaryNeoGenomics Inc (NeoGenomics) is a specialized oncology reference laboratory that provides bi...
15 May 2017 by Global Data USD $300 More Info
NeoGenomics Inc (NEO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNeoGenomics Inc (NeoGenomics) is a specialized oncology reference laboratory that provides bi...
17 Feb 2017 by Global Data USD $250 More Info
NeoGenomics Inc (NEO) - Medical Equipment - Deals and Alliances Profile
SummaryNeoGenomics Inc (NeoGenomics) is a specialized oncology reference laboratory that provides bi...
24 Jan 2017 by Global Data USD $250 More Info
NeoGenomics Inc (NEO) - Financial and Strategic SWOT Analysis Review
SummaryNeoGenomics Inc (NeoGenomics) is a specialized oncology reference laboratory that provides bi...
13 Jan 2017 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

NeoGenomics Inc (NEO) - Medical Equipment - Deals and Alliances Profile [Report Updated: 17-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data